Sort
8,912 grants matching “sars cov 2”
Impact of COVID-19 on cancer care delivery among diverse populations
$164,784Mariana C Stern · University Of Southern California · U54 · FY2020 · CA
Lipid peroxidation- and pyroptosis-induced tissue factor activation in pathogen-induced blood coagulation
$164,484Shabbir Ahmed Ansari · Beth Israel Deaconess Medical Center · K99 · FY2023 · HL
Lipid peroxidation- and pyroptosis-induced tissue factor activation in pathogen-induced blood coagulation
$164,484Shabbir Ahmed Ansari · Beth Israel Deaconess Medical Center · K99 · FY2024 · HL
immune regulation by helminths and the microbiota with SARS-Cov2 infection
$164,279P'ng Loke · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
COVID-19 Structural Vaccinology
$164,252Niraj Tolia · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Connecting the Dots: HIV, COVID-19, and Structural Racism in Gender Minority Women
$164,194Tonia C Poteat · Univ Of North Carolina Chapel Hill · R01 · FY2021 · MD
Design and development of a novel, thermostable, and inhalable dry powder COVID-19 vaccine
$164,000Nitesh K Kunda · St. John'S University · SC2 · FY2024 · GM
Design and development of a novel, thermostable, and inhalable dry powder COVID-19 vaccine
$164,000Nitesh K Kunda · St. John'S University · SC2 · FY2023 · GM
RAPID: Collaborative Research: One-step Express Test for Presymptomatic Detection to Prevent COVID-19 Spread
$164,000Slava V Rotkin · Pennsylvania State Univ University Park · · FY2020 · MPS
Design and development of a novel, thermostable, and inhalable dry powder COVID-19 vaccine
$164,000Nitesh K Kunda · St. John'S University · SC2 · FY2022 · GM
Supplement: Human Brain Collection for Study of the Neuropathogenesis of SARS-CoV-2, HIV-1, and Opioid Use Disorder
$163,967Serena S Spudich · Yale University · UM1 · FY2022 · DA
Exploring COVID-19ÃÂâÃÂÃÂÃÂÃÂs Impact on the Care and Well-being of Community Dwelling Persons with Dementia
$163,856Laura Girling · University Of Maryland Baltimore County · R21 · FY2020 · AG
Brain ACE2 in Alzheimer's disease in relation to COVID-19
$163,800Yuichiro Justin Suzuki · Georgetown University · R21 · FY2022 · AG
Exploration of Cloud Solutions to Enhance Global Infectious Diseases Research Training Program Activities
$163,791Gene D Morse · State University Of New York At Buffalo · D43 · FY2023 · TW
Measurement of Cognitive Function in Older Adults with Sensory Loss
$163,750Bonnielin Swenor · Johns Hopkins University · R21 · FY2021 · AG
MAGL PET tracer-guided prognosis and neuroprotective therapy for Alzheimer's disease
$163,671Steven H Liang · Massachusetts General Hospital · R03 · FY2020 · AG
Structural data science methods and software to study immunotherapeutic proteins
$163,647Philippe Youkharibache · Division Of Basic Sciences - Nci · ZIH · FY2023 · CA
Evaluation of Novel Technologies to Improve Clinical Management of Celiac Disease: The GLUTECH Trial
$163,367Benjamin Lebwohl · Columbia University Health Sciences · U01 · FY2025 · DK
RCT of a social-network oriented mhealth based intervention to increase access and adherence to HCV treatment and HIV viral suppression
$163,364Carl A Latkin · Johns Hopkins University · R01 · FY2020 · DA
SARS CoV2 Studies in the Helminth Immunology Section/LPD
$163,096Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
SARS-CoV-2 infection of non-human primates
$163,023Daniel Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Molecular mechanisms underlying immunosuppression and inflammation caused by SARS-CoV2 proteins
$162,946Shao-Cong Sun · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · AI
Molecular Biology of Viral Diseases
$162,811Ronald I Swanstrom · Univ Of North Carolina Chapel Hill · T32 · FY2011 · AI
HCV Ghost Sequencing Center
$162,562Todd M Allen · Massachusetts General Hospital · U24 · FY2022 · DA
Mechanisms of immunopathology of COVID-19/ARDS, and strategies to mitigate detrimental inflammatory responses
$162,424Sonja Best · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI